Peter Meldgaard

10PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 16, 2026
Longitudinal Assessment of EGFR and MET Transcriptional Activity Using Cell-Free Chromatin Immunoprecipitation in Two Patients with EGFR-Mutated Non-Small Cell Lung Cancer.

|Feb 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Maise Al Bakir, James L Reading, Samuel Gamble

|Apr 09, 2024
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes.

Theresa May, Michelle S Clement, Harkanwal Halait

|Jan 27, 2024
Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.

Christoffer Trier Maansson, Louise Skov Thomsen, Peter Meldgaard

|Dec 09, 2023
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor.

Simone Stensgaard, Astrid Thomsen, Sofie Helstrup

|Nov 14, 2023
Diagnostic Workup, Treatment Patterns, and Clinical Outcomes in Early-Stage IB-IIIA Non-Small-Cell Lung Cancer Patients in Denmark.

Ebbe Meldgaard Uldbjerg, Lars Ringgaard, Klaus Kaae Andersen

Pageof 2

Frequent Collaborators

4 joint publications

Boe Sandahl Sorensen

2 joint publications

Ebbe Meldgaard Uldbjerg

2 joint publications

Christoffer Trier Maansson

1 joint publications

Anne Tranberg Madsen